Allogeneic Transplant
What's New
Last Posted: Dec 16, 2023
- Atypical CML: diagnosis and treatment.
Massimo Breccia, et al. Hematology. American Society of Hematology. Education Program 2023 0 (1) 476-482 - Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia.
Gege Gui, et al. medRxiv : the preprint server for health sciences 2023 0 - Is a matched unrelated donor search needed for all allogeneic transplant candidates?
Ciurea Stefan O, et al. Blood advances 2018 0 (17) 2254-2261 - Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia.
Linch David C, et al. British journal of haematology 2019 0 (6) 852-859 - Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.
Ayala Rosa, et al. Cancers 2022 0 (23) - HLA-DRB3/4/5 Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation.
Tsamadou Chrysanthi, et al. Frontiers in immunology 2021 0 771449 - Diverse Approaches to Gene Therapy of Sickle Cell Disease.
White Shanna L et al. Annual review of medicine 2022 - Gene Polymorphism in Five Target Genes of Immunosuppressive Therapy and Risk of Development of Preeclampsia.
Previtera Francesca, et al. Healthcare (Basel, Switzerland) 2021 6 (7) - Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.
Aldoss Ibrahim, et al. American journal of hematology 2020 7 - FLT3-ITD positive acute myeloid leukemia: A retrospective analysis of the role of allogeneic transplant and allelic ratio in patient management.
Taylor Emma, et al. Asia-Pacific journal of clinical oncology 2018 1 - Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex.
Clay-Gilmour Alyssa I, et al. Blood advances 2017 9 (20) 1717-1728 - Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.
Ahn Jae-Sook, et al. Annals of hematology 2015 12 - Blood and Bone Marrow Transplant
From NHLBI health topic site - Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.
Jovanovic J V, et al. Leukemia 2013 10 (10) 2032-9 - Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.
Pfeiffer Tim, et al. Haematologica 2013 4 (4) 518-25 - Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
Bosch-Vizcaya Anna, et al. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012 1 (1) 100-5 - Association of stromal cell-derived factor-1-3'A polymorphism to higher mobilization of hematopoietic stem cells CD34+ in Tunisian population.
Ben Nasr M, et al. Transplantation proceedings 2011 3 (2) 635-8 - The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation.
Bogunia-Kubik K, et al. Bone marrow transplantation 2009 9 (5) 273-8 - HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype.
Torimiro J N, et al. Tissue antigens 2006 1 (1) 30-7 - Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci.
Cao K, et al. Tissue antigens 2004 4 (4) 293-325
More
About HLBS-PopOmics
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
Content Summary
Common HLBS Health Categories
Site Citation:
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 21, 2024
- Content source: